DOCSLIB.ORG

Invention Intelligence COVID-19 Special Issue

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Invention Intelligence COVID-19 Special Issue COVID-19 SPECIAL ISSUE `120 BI-MONTHLY SCIENCE & TECHNOLOGY MAGAZINE MARCH - JUNE 2020 • After COVID-19, What? • Race for a Magic Bullet to Beat COVID-19 • ICMR Leads Fight Against COVID-19 • CSIR’s Five-Pronged Strategy to Fight COVID-19 • Evolution of Coronaviruses; History of Pandemics • Interviews: Dr. Shekhar C. Mande, DG, CSIR; Prof. R.K. Dhamija, Lady Hardinge Medical College; and Dr. H. Purushotham, CMD, NRDC March-June 2020 | INVENTION INTELLIGENCE 1 2 INVENTION INTELLIGENCE | March-June 2020 CHAIRMAN & MANAGING DIRECTOR Dr. H. Purushotham CHIEF INVENTION N.G. Lakshminarayan SR. EDITOR INTELLIGENCE Radha Kant Anthwal MARCH - JUNE 2020 VOLUME 55 NUMBER 2-3 ISSN 0970-0056 Sales ARTICLES SR. EXECUTIVE OFFICER 7 After COVID-19, What? Dr. Arvind Dubey Smita Parashar 23 The Global Race for a Magic Bullet to Beat COVID-19 M. Somasekhar m 34 ICMR Leads Fight Against COVID-19 SECTION OFFICER Dr. Rajini Kant and Dr. Enna Dogra Gupta Khem Chand 41 CSIR’s Five-Pronged Strategy to Fight COVID-19 Umashankar Mishra n bimonthly magazine published by NRDC. ‘Invention Intelligence’ is an S&T Ankit Manderna n NRDC is not responsible for the 47 COVID-19 and Artificial Intelligence: The Path Forward statements and opinions of the authors published in the magazine. 51 Unlocking the Code of COVID-19: Health & Risk Communication expressed in their articles/writeups etc. n Hold the Key Dr. Manoj Kumar Patairiya 70 Viruses and Their Invisible World: Some Glimpses Dr. Subodh Mahanti The acceptance of articles/writeups 87 Evolution of Coronaviruses Biman Basu the Sr. Editor, ‘Invention Intelligence’. 81 History of Pandemics Dr. Archita Bhatta would depend entirely on the decision of n If an article received for publication is found plagiarized or translated verbatim 91 Epidemiology, Basic Reproduction Number, and Herd Immunity of SARS-CoV-2 Dr. Arun Pratap Sikarwar from any source it will be straightaway accordingly. It may even lead to 97 The world after COVID-19 Crisis Dr. Meher Wan blacklistingrejected and of the the author author. will be intimated 4 EDITORIAL n To utilise the contents published in 104 A New Scenario in Sports Rakesh Thapliyal ‘Invention Intelligence’ in any form, prior IN CONVERSATION permission of the Sr. Editor is necessary. n It is not necessary that the opinions — Dr. Shekhar C. Mande, DG, CSIR 60 “CSIR fighting unitedly against SARS-CoV-2” expressed in advertisements published in ‘Invention Intelligence’ are in 62 “Combating COVID-19 requires tough regimes of care and treatment” NRDC is not responsible for the claims — Prof. R.K. Dhamija, Lady Hardinge Medical College madeagreement in the withadvertisements. the Editorial opinion. n 66 “COVID-19 has improved the efficiency of National Innovation System” ‘Invention Intelligence’ are to be sent to CROSS-SECTION— Dr. H. Purushotham, CMD, NRDC the The Sr. articles/writeups Editor. for publication in n ` 60; 111 Gains of the Lockdown Madan Mohan ` ` 600; Three Susheela Srinivas Subscription` 900. rates: Single Copy: 114 Common Hygiene Products and the Stories Behind Them One year: 300; Two years: years: 120 CopingRESEARCH with Abnormal & DEVELOPMENT Times Dr. Sukanya Datta 126 Quest for the Unknown: Indian Research Labs Team up to Unlock the National Research Development SecretIPR CORNER of SARS-CoV-2 Dr. T.V. Venkateswaran 132 Global Patent Landscape of COVID-19 Technologies Corporation [An enterprise of DSIR, Ministry of 137 20-22, Zamroodpur Community Centre NRDC NEWS Mayuree Sengupta and Dr. H. Purushotham Science & Technology, Govt. of India] Cover Design: Parul Sinha Telephone: 091-011-29240401-07 KailashFax: Colony 091-011-29240409, Extension, New 29240410 Delhi-110048 E-mail: Website: March-June 2020 | INVENTION INTELLIGENCE 3 CIN: U74899 [email protected] 1987 GOI 002354 http://www.nrdcindia.com EDITORIAL KNOWING ABOUT COVID-19 T he year 2020 started with the COVID-19 global pandemic. We are in the middle of the current year, but even now it cannot be said with certainty when the deadly march of the SARS-CoV-2 will be halted and how long we will have to face the fury of this pandemic. So far, the pandemic has infiltrated into 215 Wecountries are living of the in worldunprecedented leading to troubled over 10 timesmillion and infections our almost and every0.50 million activity deaths. is affected. The COVID-19- this March-June 2020 combined issue of Invention Intelligence induced lockdown also halted the printing and mailing process of magazines, necessitating publication of . This issue is focused on COVID-19 in which we have tried to cover various aspects of this topic. At present, we do not have any specific drug or vaccine in hand to fight COVID-19. So, no one should take it casually. There should be no relaxation in hand washing, wearing a mask, social distancing and other preventive measures. Looking at the developments till now, we can get assured that the day will come when we will celebrate the victory over this pandemic. But by then many things in our society will have possiblechanged postulatesforever or areat least presented for very here. long periods. How this pandemic will change the global scenario in terms of interpersonal relations, social relations, habits, trade, and economy is difficult to guess, but some drugsThe unfolding and vaccines ‘new tonormal’ beat COVID-19 and many are other covered related in thepoints article are ‘Theelaborated Global inRace the for articles a Magic ‘After Bullet COVID-19, to Beat What’, and ‘The World after COVID-19 Crisis’. The intensified efforts across the world on development of Govt. of India and Dr. V. K. Paul, Member NITI Aayog at the National Media Centre on 28 May 2020, on the developmentCOVID-19’ with of indigenousa report on COVID-19the press vaccines.meet of Professor K. VijayRaghavan, Principal Scientific Advisor to On 29 June 2020, Hyderabad-based Bharat Biotech had announced that their vaccine candidate for COVID-19, COVAXIN, which they have developed in association with the ICMR (Indian Council for Medical developmentResearch), has also been features given inapproval this issue. by CDSCO (Central Drugs Standard Control Organisation) for Phase I and II human clinical trials that are scheduled to start across the country in July. This new Indian An article, ‘ICMR Leads Fight Against COVID-19’, highlights the role of ICMR — the apex body in India for the formulation, coordination and promotion of biomedical research — and its response to implement scientific interventions to combat the pandemic. Five technology verticals set up by the Council of Scientific and Industrial Research (CSIR) for addressing the emerging situation are described in the article ‘CSIR’s Five-Pronged Strategy to Fight COVID-19’. The article, ‘Unlocking the Code of COVID-19: Health & Risk Communication Hold the Key’, gives details of the National Health & Risk Communication Programme — Year of Awareness on Science & Health (YASH), which has been initiated by the National Council for Science & Technology Communication (NCSTC), Dept. of Science & Technology, Govt. of India to combat such risks and mitigate the crises with the help of public awareness and preparedness. The Indian Government has launched an AI portal (https://indiaai.in/),where all the recent AI-related developments will be shared among the citizens of the country. This development has given a boost to AI enthusiasts, which will eventually help in strengthening the research activity in this field. The importance 4 INVENTION INTELLIGENCE | March-June 2020 of AI in healthcare, especially during the COVID-19 pandemic, is described in the article ‘COVID-19 and Artificial Intelligence:Viruses Theand Pathalmost Forward’. all the important aspects of SARS-CoV-2, including the natural origin of SARS-CoV-2, are discussed in the articles Glimpses’; ‘Evolution of Coronaviruses’; and ‘Epidemiology,‘Viruses and TheirBasic InvisibleReproduction World: Number, Some inand the Herd study Immunity of pandemics, of SARS-CoV-2’. the mechanism The article of their‘History occurrence, of Pandemics’ the application chronicles of the molecular progress genetics leading to better understanding of immunology, microbiology and genomics-accelerated vaccinology. Invention Intelligence, Dr. Shekhar C. Mande, DG, CSIR, speaks about the multifarious talksIn conversation about his initiativewith to bring out the Compendium of Indian Technologies for Combating COVID-19, a ways in which CSIR is contributing to the fight against the SARS-CoV-2; Dr. Purushotham, CMD, NRDC, Prof. Rajinder Kumar Dhamija, a prominent neurologist, currently heading the Department of Neurology compilation of COVID-19 related technologies, and other issues related with the current pandemic; and related to COVID-19. at Lady Hardinge Medical College, New Delhi, talks about the neurological and various other health aspects COVID-19 pandemic has led to either cancellation or postponement of domestic and international The year 2020 will also go down in the history of world sports as a year of the unprecedented. The championships as well as training sessions all over the world, including the biggest sporting extravaganza — the Tokyo Olympics 2020. In this issue, an article, titled ‘A New Scenario in Sports’, gives a glimpse of the world of sports in the new scenario. In the ‘Cross-Section’ column, we discuss gains of lockdowns and common hygiene products, which have become important tools to fight SARS-CoV-2, as also the stories behind these products, and how to cope with the abnormal times. In the ‘IPR Corner’, patent issues related with the COVID-19 technologies are discussed. Recently, a patent application has been filed for the NavRakshak PPE by the inventors through NRDC. The manufacturing know-how of NavRakshak PPE has been developed at the Innovation Cell of the Institute of Naval Medicine, INHS Asvini Hospital (Mumbai) of the Indian Navy, and is assigned to NRDC for commercialisation. It is cost-effective as it does not require any major capital investment and can be adopted even by gown kits.manufacturing These six manufacturersunits using basic put stitching together expertise.
Load more

Recommended publications
  • What Do We Know About India's Covaxin Vaccine?
    FEATURE Tamil Nadu, India COVID-19 VACCINES [email protected] BMJ: first published as 10.1136/bmj.n997 on 20 April 2021. Downloaded from Cite this as: BMJ 2021;373:n997 http://dx.doi.org/10.1136/bmj.n997 What do we know about India’s Covaxin vaccine? Published: 20 April 2021 India has rapidly approved and rolled out Covaxin, its own covid-19 vaccine. Kamala Thiagarajan examines what we know so far. Kamala Thiagarajan freelance journalist Who developed Covaxin? cheapest purchased by any country in the world at 206 rupees per shot for the 5.5 million doses the Covaxin was developed by Indian pharmaceutical government currently has on order. The government company Bharat Biotech in collaboration with the has capped the price of the vaccine sold in the private Indian Council of Medical Research, a government market, with private hospitals able to charge up to funded biomedical research institute, and its 250 rupees.13 subsidiary the National Institute of Virology. Covaxin does not require storage at sub-zero Bharat Biotech has brought to market 16 original temperatures, which would be hard to maintain in vaccines, including for rotavirus, hepatitis B, Zika India’s climate and with the frequent power cuts in virus, and chikungunya.1 The company reportedly rural areas. Covaxin is available in multi-dose vials spent $60-$70m (£43-£50m; €50-€58m) developing and is stable at the 2-8°C that ordinary refrigeration Covaxin.2 can achieve. How does Covaxin work? Bharat Biotech says it has a stockpile of 20 million The vaccine is similar to CoronaVac (the Chinese doses of Covaxin for India and is in the process of vaccine developed by Sinovac)3 in that it uses a manufacturing 700 million doses at its four facilities complete infective SARS-CoV-2 viral particle in two cities by the end of the year.
    [Show full text]
  • Plant Viruses
    Western Plant Diagnostic Network1 First Detector News A Quarterly Pest Update for WPDN First Detectors Spring 2015 edition, volume 8, number 2 In this Issue Page 1: Editor’s Note Dear First Detectors, Pages 2 – 3: Intro to Plant Plant viruses cause many important plant diseases and are Viruses responsible for huge losses in crop production and quality in Page 4: Virus nomenclature all parts of the world. Plant viruses can spread very quickly because many are vectored by insects such as aphids and Page 5 – Most Serious World Plant Viruses & Symptoms whitefly. They are a major pest of crop production as well as major pests of home gardens. By mid-summer many fields, Pages 6 – 7: Plant Virus vineyards, orchards, and gardens will see the effects of plant Vectors viruses. The focus of this edition is the origin, discovery, taxonomy, vectors, and the effects of virus infection in Pages 7 - 10: Grapevine plants. There is also a feature article on grapevine viruses. Viruses And, as usual, there are some pest updates from the West. Page 10: Pest Alerts On June 16 – 18, the WPDN is sponsoring the second Invasive Snail and Slug workshop at UC Davis. The workshop Contact us at the WPDN Regional will be recorded and will be posted on the WPDN and NPDN Center at UC Davis: home pages. Have a great summer and here’s hoping for Phone: 530 754 2255 rain! Email: [email protected] Web: https://wpdn.org Please find the NPDN family of newsletters at: Editor: Richard W. Hoenisch @Copyright Regents of the Newsletters University of California All Rights Reserved Western Plant Diagnostic Network News Plant Viruses 2 Ag, Manitoba Photo courtesy Photo Food, and Rural Initiatives and Food, of APS Photo by Giovanni Martelli, U of byBari Giovanni Photo Grapevine Fanleaf Virus Peanut leaf with Squash Mosaic Virus tomato spotted wilt virus Viruses are infectious pathogens that are too small to be seen with a light microscope, but despite their small size they can cause chaos.
    [Show full text]
  • Bcpct]Ttsbc^Prc U^A Dq[XRV^^S
    6 < %()(=#%% 53%7==,>3='$()6(=#%% (#-'>3='$()6(=#%% $'()"*$+&,- %( !"# $$%& 2(*3-% (566)(37)% 3 0 4 $5 3 $1 2 0 .8 9 8 ++0 0 .:; . !" . / 01 $ %'( $) '# *' it for the last eight to nine notable achievements to its months, “where is the UN in name in the 75 years of its aking a strong case for a this joint fight. Where is the experience, including the pre- Msignificant role for India effective response.” vention of a third world war, in the United Nations, Prime Focussing on a more “we can’t deny terrorist attacks 0 Minister Narendra Modi on prominent role for India in the shook the world”. Saturday stressed the need for UN and fight against corona, “We have successfully ne of the oldest partners changes in the international the Prime Minister avoided avoided a third world war but Oof the BJP — the body and questioned its posi- making any reference to ongo- we cannot deny many wars Shiromani Akali Dal — which tion in fighting the coron- ing tension at the Line of happened, many civil wars has been with it through thick avirus pandemic. Actual Control (LAC) and happened. Terrorist attack and thin for decades, finally He also assured the global frosty ties with Pakistan in his shook the world. Blood was quit the National Democratic Q community that India will pro- 20-minute speech. He also did spilled. Those were killed were Alliance (NDA) on Saturday, vide corona vaccine to the not respond to Pakistan Prime like you and me. Children left signaling a complete political world as it is the world’s biggest Minister Imran Khan’s remarks the world prematurely,” he said.
    [Show full text]
  • New Challenges and Opportunities for Innovation Peter Piot, London
    Professor Peter Piot’ Biography Baron Peter Piot KCMG MD PhD is the Director of the London School of Hygiene & Tropical Medicine, and the Handa Professor of Global Health. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations (1995-2008). A clinician and microbiologist by training, he co-discovered the Ebola virus in Zaire in 1976, and subsequently led pioneering research on HIV/AIDS, women’s health and infectious diseases in Africa. He has held academic positions at the Institute of Tropical Medicine, Antwerp; the University of Nairobi; the University of Washington, Seattle; Imperial College London, and the College de France, Paris, and was a Senior Fellow at the Bill & Melinda Gates Foundation. He is a member of the US National Academy of Medicine, the National Academy of Medicine of France, and the Royal Academy of Medicine of his native Belgium, and is a fellow of the UK Academy of Medical Sciences and the Royal College of Physicians. He is a past president of the International AIDS Society and of the King Baudouin Foundation. In 1995 he was made a baron by King Albert II of Belgium, and in 2016 was awarded an honorary knighthood KCMG. Professor Piot has received numerous awards for his research and service, including the Canada Gairdner Global Health Award (2015), the Robert Koch Gold Medal (2015), the Prince Mahidol Award for Public Health (2014), and the Hideyo Noguchi Africa Prize for Medical Research (2013), the F.Calderone Medal (2003), and was named a 2014 TIME Person of the Year (The Ebola Fighters).
    [Show full text]
  • Overview of Aarogya Setu Application Shweta Devidas Kedare1
    International Research Journal of Engineering and Technology (IRJET) e-ISSN: 2395-0056 Volume: 07 Issue: 06 | June 2020 www.irjet.net p-ISSN: 2395-0072 Overview of Aarogya Setu Application Shweta Devidas Kedare1 1Shweta Devidas Kedare, Department of Master of Computer Application, ASM IMCOST, Maharashtra, India ---------------------------------------------------------------------***--------------------------------------------------------------------- Abstract - The app - Aarogya Setu, which means "bridge to health" in Sanskrit -It is an Indian app which was launched on April 2nd 2020, by Indian government. It is designed as a Coronavirus, or COVID-19 contact tracing app that uses the Bluetooth and location technology in phones to note when you are near another user who also uses the Aarogya Setu app. In case someone you have come in close proximity to is confirmed infected, you are alerted. The app alerts are produced by instructions on how to self-isolate and what to do in case you develop symptoms. Basically this app gives basic information about Covid-19, including hygiene and social distancing protocols. It also has details of how one could donate to the prime minister’s coronavirus-specific relief fund, PM-Cares. India has made it mandatory for government and private sector employees to download it But users and experts in India and around the world say the app raises huge data security concerns. KeyWords: security, data, private, information, COVID-19, technology, location, bluetooth, proximity, etc. 1. INTRODUCTION Since the risk of COVID-19 started increasing in India so, The government of India decided to launch the application, name Aarogya Setu, which was intended to monitor the ratio of COVID-19 patients in India .This app is an updated version of an earlier app called Corona Kavach (now discontinued) which was released earlier by the Government of India.
    [Show full text]
  • A Review of India's Contact-Tracing App, Aarogya Setu
    Doc Title A Review of India’s Contact-Tracing App, Aarogya Setu A - Front Page two line title ARTICLE A Review of India’s Contact-tracing App, Aarogya Setu The Government of India’s Ministry of Electronics and Information Technology (MeitY) agency launched Aarogya Setu, a contact-tracing mobile application. Aarogya Setu has been created by the National Informatic Centre (NIC) in response to the COVID-19 crisis, as a way to collect and understand public health-related data.1 The application uses mobile phones to perform a cross reference of individuals’ data with the database held by Indian Council of Medical Research (ICMR), “On various online discussion which was specially created as part of ongoing COVID-19 testing infrastructure. forums, there is significant The purpose of Aarogya Setu is to notify users whether they have been exposed interest in the workings of this to COVID-19, by checking their proximity to known patients. In the event of a government- managed app match, the application will warn other users in the area that an infected person and its use of personal and is in their proximity. According to the press release dated May 26, 2020 available sensitive user data..”123 on mygov.in website, roughly 114 million users have adopted the app.2 Aarogya Setu also collects some sensitive personal information including gender and recent travel information. This has raised privacy and security questions. This whitepaper evaluates the functionality and data privacy aspects of the application. About Aarogya Setu Aarogya Setu app is a self-assessment disease monitoring app launched by the Indian government.
    [Show full text]
  • Covid-19 Tracing Contacts Apps: Technical and Privacy Issues
    Int. J. Advance Soft Compu. Appl, Vol. 12, No. 3, November 2020 ISSN 2074-8523; Copyright © ICSRS Publication, 2020 www.i-csrs.org Covid-19 Tracing Contacts Apps: Technical and Privacy Issues Salaheddin J. Juneidi Computer Engineering Department, Palestine Technical University Khadoorei1, Hebron, West Bank Palestine. e-mail: [email protected] Received 20 July 2020; Accepted 5 October 2020 Abstract Since the start of the year 2020 the world is facing an outbreak of Covid-19 pandemic, technical specialists all over the universe have been scrambling to develop services, apps, and system’s protocols for contactors tracing, with the objective to identify and to notify everyone that gets close with an individual carrier. Some of these apps are lightweight and temporary, while others are diffuse and aggressive. Some of tracing services are developed locally by small interested programmers, while others are large-scale international operations. To date, we have recognized more than 25 large automated contact tracing efforts around the globe, included with details about what they were, how they worked, and the procedures and conditions that were put in place around them. This paper will deal with general data of the most prominent applications in terms of technical approaches used in the world and compare them with regard to the efficiency of tracking covid-19 and compare them with concerning of the people’s privacy who use these apps. Keywords: Covid-19, GPS location, Blue trace, Google/Apple, DP-3T, Apps, Privacy. 1. Introduction Many applications, services and systems have been proposed and launched [1] with an aim to track and identify infected people with objective to reduce or even to prevent physical contact with other people, some of these tracking 1 Special thanks to Palestine Technical University -Khadoorei for continuous support of research efforts Salaheddin J.
    [Show full text]
  • International Congress on Targeting Ebola 28
    CONFERENCE REPORT Journal of Virus Eradication 2015; 1: 282–283 International Congress on Targeting Ebola 28–29 May 2015, Pasteur Institute, Paris Sabine Kinloch-de Loës1* and Colin S Brown2,3 1 Division of Infection and Immunity, Royal Free Hospital, London, UK 2 Hospital for Tropical Diseases, University College Hospital London, UK 3 King‘s Sierra Leone Partnership, King‘s Centre for Global Health, King‘s Health Partners and King‘s College London, UK Introduction messages throughout the meeting. Professor Piot, one of the discoverers of the Ebola virus, described a recent return to The International Congress on Targeting Ebola 2015 was held on Yambuku in the DRC, the site of the first EVD outbreak in 1976. 28–29 May 2015 at the Pasteur Institute in Paris (www.targeting- The current state of the healthcare infrastructure did not reflect ebola.com). The meeting was organised in partnership with the the many promises of future investments made at the time of the COPED of the French Academy of Sciences, the French Task Force outbreak, a poignant reminder that we must not assume that Group for Ebola, the Pasteur Institute and the Task Force for current promises of investment will always materialise. Infectious Diseases. Publication of a summary of the meeting by the organisers is anticipated in an open-access journal. This paper Professor Muyembe-Tamfum, a microbiologist with four decades aims to provide a brief overview of the main discussion points of EVD experience, warned how outbreaks have become more during the meeting. frequent since 2012 in the DRC, both with the Zaire ebolavirus (EBOV) strain now seen in West Africa, and the Bundibuyo ebolavirus This meeting brought together more than 300 experts in the field (BDBV).
    [Show full text]
  • Home Based Internship Certificate
    HOME BASED INTERNSHIP CERTIFICATE This is to certify that Dhanush R, Reg. No. AME 19012 of B.E - Marine Engineering, AMET University, Chennai has undergone with a Home Based Internship, titled “Influenza Virus” from 1st April 2020 to 28th April 2020 during the academic year 2019-2020 and has successfully completed his internship programme. Faculty In-charge Principal – DGS Courses INTERNSHIP AT HOME A Report On Internship In DEPARTMENT OF MARINE ENGINEERING By Name : Dhanush R Registration Number : AME19012 Year : 1ST Year Batch : BE(ME)-19 Group : 1 1 Influenza Virus SARS-CoV-2, a member of the family Coronaviridae A virus is a sub microscopic infectious agent that replicates only inside the living cells of an organism. Viruses can infect all types of life forms, from animals and plants to microorganisms, including bacteria and archaea. Since Dmitri Ivanovsky's 1892 article describing a non-bacterial pathogen infecting tobacco plants, and the discovery of the tobacco mosaic virus by Martinus Beijerinck in 1898, more than 6,000 virus species have been described in detail, of the millions of types of viruses in the environment. Viruses are found in almost every ecosystem on Earth and are the most numerous type of biological entity. The study of viruses is known as virology, a subspeciality of microbiology. When infected, a host cell is forced to rapidly produce thousands of identical copies of the original virus. When not inside an infected cell or in the process of infecting a cell, viruses exist in the form of independent particles, or virions, consisting of: (i) the genetic material, i.e.
    [Show full text]
  • Lecture 7 Introduction to Viruses Introduction
    Lecture 7 Introduction to Viruses Introduction Virus, parasite with a noncellular structure composed mainly of nucleic acid within a protein coat. Most viruses are too small (100–2,000 Angstrom units) to be seen with the light microscope and thus must be studied by electron microscopes. In one stage of their life cycle, in which they are free and infectious, virus particles do not carry out the functions of living cells, such as respiration and growth; in the other stage, however, viruses enter living plant, animal, or bacterial cells and make use of the host cell's chemical energy and its protein- and nucleic acid–synthesizing ability to replicate themselves. Over 5,000 species of viruses have been discovered. Discovery of Viruses In 1884 the French microbiologist Charles Chamberland invented a filter, known today as the Chamberland filter or Chamberland–Pasteur filter that has pores smaller than bacteria. Thus he could pass a solution containing bacteria through the filter and completely remove them from the solution. In the early 1890s the Russian biologist Dmitri Ivanovsky used this filter to study what became known as the tobacco mosaic virus. His experiments showed that extracts from the crushed leaves of infected tobacco plants remain infectious after filtration. At the same time several other scientists proved that, although these agents (later called viruses) were different from bacteria, they could still cause disease, and they were about one hundredth the size of bacteria. In 1899 the Dutch microbiologist Martinus Beijerinck observed that the agent multiplied only in dividing cells. Having failed to demonstrate its particulate nature he called it a "contagium vivum fluidum", a "soluble living germ".
    [Show full text]
  • Vaccine Matri: a New Way of Diplomacy
    AN EXPLORATORY STUDY OF ROLE OF INDIA IN VACCINE DIPLOMACY FOR COVID-19 PANDEMIC ERA Turkish Online Journal of Qualitative Inquiry (TOJQI) Volume 12, Issue 3, June 2021:652- 665 Research Article An Exploratory Study Of Role Of India In Vaccine Diplomacy For Covid-19 Pandemic Era Dr. Saroj Choudhary1, Dr Sanjiv Singh Bhadauria2, Mr Abhinav Upadhyay3, Dr Sandeep Kulshrestha4 Abstract Coronavirus is spread in end of December, 2019 in Wuhan and in March, 2020 World Health Organization declared it as a pandemic. Coronavirus affect world in many ways like socially, economically and in many other. In early January, 2021 India make their vaccine and not only vaccinated their own people but also help other countries and provide vaccine to their neighbouring countries on grant and commercial basis and this will help India to make their reputation in world platform. In this paper, Vaccine Maîtri an initiative by India to provide vaccine to their neighbouring countries and also other needy countries and how this will enhance the image of India in world stage. Keywords: Coronavirus; COVID-19; vaccine maîtri; vaccine; India;government; WHO. VACCINE MATRI: A NEW WAY OF DIPLOMACY COVID-19 is a major global public health challenge, and in many countries it has created a serious social, economic, and political crisis. The numbers involved are staggering, whether they refer to infection and death, the rate of public health measures such as travel restrictions, or the economic consequences of unemployment and public sector spending. All economies are placed in drug-induced comas, the complex public health systems have become increasingly prevalent in levels of public adherence or surprising disobedience, and health care systems and provinces are being tested by many who have never seen it.
    [Show full text]
  • Announcement on Procurement Process
    Announcement on Procurement Process During the past few weeks, there have been reports in the media at large misrepresenting the procurement process of COVAXIN®, in Brazil and other countries. We wish to provide the following clarification - ∙ The procurement process for COVID-19 vaccines and several vaccines for routine immunization follow a common process which is widely accepted, and established in Industry ∙ Based on a country’s requirement, the company receives a letter of intent (or MOU) for procurement ∙ The company then proceeds to apply for emergency use authorization (EUA) in the respective country ∙ Once EUA is received, the Ministry of Health (MOH) would proceed to place a firm order by releasing a purchase order, with the required initial quantities. In several countries, MOHs have placed orders for procurement prior to the approval of vaccines such as USA, EU, India, etc. However, procurement happens only post EUA. ● In order to secure a firm Purchase Order from the country, the company proceeds to raise a Pro Forma Invoice to the MOH, towards the supply of vaccine ● Based on the invoice, the MOH pays the amount in advance ● Once the payment is received, the company proceeds to supply the agreed quantities and within the agreed timelines ● In the specific case of procurement of COVAXIN® by MOH Brazil, since the first meetings with MOH Brazil during Nov 2020, until 29th of June 2021, a step-by-step approach has been followed towards contracts, and regulatory approvals, during this ~ 8 long month-long process. On 4th June 2021, ANVISA authorized the exceptional import of the Covaxin vaccine by the Ministry of Health for distribution and Use Under Controlled Conditions”.
    [Show full text]